Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
12/01/2021
Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry
Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry
Novel Oncology Embolic Device...
12/01/2021
IO Learning

Advertisement

News
Cardiac Safety Research Consortium (CSRC) think tank to bring FDA, EMA and international stakeholders together to reassess cardiovascular safety in oncology trials
11/30/2021
Durham, NC, November, 29, 2021 – Cardiovascular Safety Research Consortium (CSRC) will convene a broad group of stakeholders including U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) representatives,...
Durham, NC, November, 29, 2021 – Cardiovascular Safety Research Consortium (CSRC) will convene a broad group of stakeholders including U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) representatives,...
Durham, NC, November, 29, 2021...
11/30/2021
IO Learning
News
SIO Announces ACCLAIM Clinical Trial with Groundbreaking Support from Industry Partners
11/18/2021
Washington DC (18 November 2021) – The Society of Interventional Oncology (SIO) announces the launch of the society’s first clinical trial, “Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective Trial...
Washington DC (18 November 2021) – The Society of Interventional Oncology (SIO) announces the launch of the society’s first clinical trial, “Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective Trial...
Washington DC (18 November 2021)...
11/18/2021
IO Learning
News
Philips brings clarity to every moment of cancer care with new patient-centered innovations at ASTRO 2021
11/05/2021
Multimodality RT Simulation Workspace will provide a single space for multimodality image fusion and contouring.
Multimodality RT Simulation Workspace will provide a single space for multimodality image fusion and contouring.
Multimodality RT Simulation...
11/05/2021
IO Learning

Advertisement

News
Radboud university medical center study sets new milestone with 90% diagnostic accuracy of lung nodules suspected of cancer using Philips technology for bronchoscopic procedures
11/05/2021
Hospital achieves world-first level of improvement in the diagnostic accuracy of navigation bronchoscopy using Philips Lung Suite combined with the company’s Image Guided Therapy System – Azurion
Hospital achieves world-first level of improvement in the diagnostic accuracy of navigation bronchoscopy using Philips Lung Suite combined with the company’s Image Guided Therapy System – Azurion
Hospital achieves world-first...
11/05/2021
IO Learning
News
Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery
11/02/2021
Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery
Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery
Fluidx Medical’s GPX Embolic...
11/02/2021
IO Learning
News
ABK Biomedical Announces Enrollment Initiation of First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
11/01/2021
HALIFAX, NS, Nov. 1, 2021 /PRNewswire/ - ABK Biomedical, Inc., an innovative, clinical stage medical device company dedicated to the research, development and commercialization of advanced embolic therapies, announced the...
HALIFAX, NS, Nov. 1, 2021 /PRNewswire/ - ABK Biomedical, Inc., an innovative, clinical stage medical device company dedicated to the research, development and commercialization of advanced embolic therapies, announced the...
HALIFAX, NS, Nov. 1,...
11/01/2021
IO Learning

Advertisement

News
IceCure Medical Announces New Independent Data Published in the Journal of Cancer Therapy Showing that Percutaneous Cryoablation Presents a Potential Substitute for Lumpectomy for Tumors <15mm using ProSense™
11/01/2021
CAESAREA, Israel,&nbsp;Nov. 1, 2021&nbsp;/PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of the next generation minimally invasive cryoablation technology that destroys tumors by...
CAESAREA, Israel,&nbsp;Nov. 1, 2021&nbsp;/PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of the next generation minimally invasive cryoablation technology that destroys tumors by...
CAESAREA, Israel,&nbsp;Nov. 1,...
11/01/2021
IO Learning
News
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting
10/28/2021
Often undetected until it has spread elsewhere in the body, pancreatic cancer is the third leading cause of cancer death in the United States, with a mortality rate of roughly 80 percent. At diagnosis, only about 20 percent of pancreatic...
Often undetected until it has spread elsewhere in the body, pancreatic cancer is the third leading cause of cancer death in the United States, with a mortality rate of roughly 80 percent. At diagnosis, only about 20 percent of pancreatic...
Often undetected until it has...
10/28/2021
IO Learning
News
HistoSonics Receives FDA "Breakthrough Device Designation" for Novel Sonic Beam Therapy
10/25/2021
Breakthrough status for new histotripsy targeted liver therapy will help provide timely access to non-invasive liver treatment (PRNewsfoto/HistoSonics, Inc.)
Breakthrough status for new histotripsy targeted liver therapy will help provide timely access to non-invasive liver treatment (PRNewsfoto/HistoSonics, Inc.)
Breakthrough status for new...
10/25/2021
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster. &nbsp; Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster. &nbsp; Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use